<DOC>
	<DOCNO>NCT01090596</DOCNO>
	<brief_summary>Using tissue sample obtain previous study , effect naproxen gene expression profile antral mucosal tissue assess . We hypothesize distinct change gene expression profile sample take individual treat naproxen versus sample take individual treat placebo .</brief_summary>
	<brief_title>Changes mRNA Expression Following Exposure Naproxen</brief_title>
	<detailed_description>We use microarray technology quantify transcriptome-wide change gene expression said-samples .</detailed_description>
	<mesh_term>Naproxen</mesh_term>
	<criteria>Healthy adult age 18 75 inclusive Written inform consent prior undergo study procedures A physical examination reveals clinically significant abnormality Female subject childbearing potential must take acceptable form contraceptive Any mucosal break within 2 cm pyloric channel see baseline endoscopy Any GDU &gt; 5 gastroduodenal erosion baseline endoscopy CXB , CPG , ASA , NSNSAID use within prior 2 week Previous gastrointestinal ulcer Hypersensitivity allergy NSAIDs , ASA , CPG , CXB contraindication take treatment Baseline complaint abdominal pain , nausea , and/or cramp Any acid block medication include antacid , H2 receptor blocker within prior 2 week , PPI use within prior 30 day Corticosteroids use within prior 60 day Any document bleeding tendency Has take warfarin within prior 60 day Three great alcoholic beverage daily History cerebrovascular event</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2010</verification_date>
</DOC>